Medical technology business Smith+Nephew has confirmed plans to build an £80m research and development and manufacturing facility in East Yorkshire.
The project at commercial property developer Wykeland Group’s Melton West business park is expected to open in 2024.
Subject to planning approval, Smith+Nephew will build a new facility for its Advanced Wound Management franchise creating a world-class R&D, manufacturing and flexible office environment.
Dominic Gibbons, Managing Director of Hull-based Wykeland, owner and developer of Melton West, said: “We are delighted the strategic, long-term investments we have made in the infrastructure at Melton West business park have enabled Smith+Nephew to stay within the region and make such a huge investment in a state-of-the-art new facility.
“Smith+Nephew is one of the region’s leading employers, with a proud local history and heritage. This investment will open an exciting new chapter in that story.”
Simon Fraser, President of Advanced Wound Management for Smith+Nephew, said: “This major investment demonstrates our commitment to the UK and to building our leadership in Advanced Wound Management.
“Smith+Nephew was founded in Hull in 1856 and we are proud to make this major investment in the region for future generations.”
The 200-acre Melton West business park enjoys a prime location west of Hull, off the A63 and connecting to the national motorway network within minutes via the M62.
The Smith+Nephew facility will be the latest major development at the growing site, which features more than one million sq ft of completed warehouse, distribution, manufacturing and office space.